AI for drug discovery: What can we do
Over the past few years, artificial intelligence (AI) has emerged in the drug discovery field. AI drug design is developed from the simplified molecular-input line-entry system (SMILES) string to a graph neural network which has improved accuracy and efficiency of de novo drug design discovery
Japan team carries out world-first spinal cord stem cell trial
There is currently no effective treatment for paralysis caused by serous spinal cord injuries, and more than 100,000 people in Japan are affected alone.
